Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

Alaunos Therapeutics, Inc. to acquire Velaris Therapeutics

Announced Oct 13, 2026 · Announced · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Alaunos Therapeutics, Inc. (TCRT)
Target
Velaris Therapeutics
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Announced

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Cantor Fitzgerald
To the target
Wedbush

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.2) · Oct 13, 2026

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.